Description

Mazdutide represents a synthetic peptide designed as a dual agonist with activity at both glucagon-like peptide-1 (GLP-1) and glucagon receptors, providing a unique approach for investigating metabolic regulation through combined incretin and glucagon signaling. The compound incorporates structural modifications designed to achieve balanced activity at both receptor systems while maintaining stability for research applications. Mazdutide functions through simultaneous activation of GLP-1 and glucagon receptors, leading to complementary signaling cascades that influence glucose homeostasis, energy expenditure, and metabolic regulation. The dual receptor activity profile provides opportunities for investigating the combined effects of incretin and glucagon signaling pathways in metabolic research. Research applications include examination of dual-receptor metabolic signaling, glucose homeostasis mechanisms, and metabolic pathway interactions. For research use only.